ONC
BeOne Medicines Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$371.56
−0.48%Forward multiples
Based on analyst estimates
- P/E forward
- 44.27x
- P/E 2026E
- 51.03x
- P/E 2027E
- 36.18x
- P/E 2028E
- 27.04x
- P/S forward
- 5.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.89x
- PEG TTM
- —
- Price / book
- 8.17x
- Price / sales
- 6.89x
- Price / cash flow
- 25.06x
Enterprise value
- Enterprise value
- $38.3B
- EV / sales
- 6.25x
- EV / EBITDA
- 33.03x
- EV / EBIT
- 41.48x
- Market cap
- $42.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026